Virpax Pharmaceuticals (VRPX) Insider Trading & Ownership $1.34 -0.14 (-9.46%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.35 +0.01 (+0.45%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virpax Pharmaceuticals (NASDAQ:VRPX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.70%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$113,090.00Number OfInsiders Selling(Last 3 Years)0 Get VRPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Virpax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRPX Insider Buying and Selling by Quarter Remove Ads Virpax Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/24/2022Jerrold SendrowDirectorBuy18$322.50$5,805.00 5/18/2022Anthony P MackCEOBuy303$335.00$101,505.00 5/18/2022Eric FloydDirectorBuy17$340.00$5,780.00 (Data available from 1/1/2013 forward) VRPX Insider Trading Activity - Frequently Asked Questions Who is on Virpax Pharmaceuticals's Insider Roster? The list of insiders at Virpax Pharmaceuticals includes Anthony P Mack, Eric Floyd, and Jerrold Sendrow. Learn more on insiders at VRPX. What percentage of Virpax Pharmaceuticals stock is owned by insiders? 3.70% of Virpax Pharmaceuticals stock is owned by insiders. Learn more on VRPX's insider holdings. Virpax Pharmaceuticals Key ExecutivesMr. Gerald W. Bruce (Age 67)CEO & Director Compensation: $371.87kMr. Vinay Shah A.C.A. (Age 61)M.B.A., CFO, Principal Financial Officer, Principal Accounting Officer & Corporate Secretary Compensation: $238kDr. Sheila A. Mathias J.D. (Age 56)M.B.A., Ph.D., Chief Scientific Officer Compensation: $698.97kMs. Shana PanzarellaChief of Staff More Insider Trading Tools from MarketBeat Related Companies PLX Insider Selling TVGN Insider Selling CKPT Insider Selling LFVN Insider Selling NMRA Insider Selling CRGX Insider Selling AMRN Insider Selling TNGX Insider Selling KOD Insider Selling ACRS Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:VRPX) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump's 100-Day Plan Triggers Global RetaliationIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRPX Stock Free VRPX Stock Alerts